McConnell R J, Menendez C E, Smith F R, Henkin R I, Rivlin R S
Am J Med. 1975 Sep;59(3):354-64. doi: 10.1016/0002-9343(75)90394-0.
Taste and smell functions were measured in 18 unselected patients with untreated primary hypothyroidism, and in 15 of the 18 patients after treatment with thyroid hormones. Before treatment, 9 of the 18 patients (50 per cent) were aware of some alteration in their sense of taste, and 7 of the 18 patients (39 per cent) were aware of some alteration in their sense of smell. Distoritions of tase (dysgeusia) and smell (dysosmia) were frequent complaints among the untreated patients; dysgeusia was observed by 7 patients (39 per cent) and dysosmia by 3 patients (17 per cent). Median detection and recognition thresholds for four taste stimuli salt (sodium chloride), sweet (sucrose), sour (hydrochloric acid) and bitter (urea), and for two smell stimuli (pyridine and nitrobenzene), were determined in each patient before and after treatment with thyroid hormones. Before treatment, decreased taste acuity (hypogeusia) for at least one stimulus was observed in 14 of the patients (83 per cent); the most common abnormalities were in the detection and recognition of bitter stimuli. Median detection thresholds for both smell stimuli were also markedly elevated (hyposmia) before therapy. Treatment with throid hormones largely reversed both the taste and smell defects. In one patient, taste and smell abnormalities were completely corrected after 16 days of treatment with thyroxine. This study indicates that taste and smell defects are common clinical abnormalities in primary hypothyroidism, and suggests that these defects may contribute to the anorexia and lack of interest in eating which are frequently observed.
对18例未经治疗的原发性甲状腺功能减退症患者的味觉和嗅觉功能进行了测量,并对其中15例患者在接受甲状腺激素治疗后进行了测量。治疗前,18例患者中有9例(50%)意识到自己的味觉有某种改变,18例患者中有7例(39%)意识到自己的嗅觉有某种改变。味觉扭曲(味觉障碍)和嗅觉扭曲(嗅觉障碍)是未治疗患者中常见的主诉;7例患者(39%)出现味觉障碍,3例患者(17%)出现嗅觉障碍。在每位患者接受甲状腺激素治疗前后,测定了四种味觉刺激物盐(氯化钠)、甜(蔗糖)、酸(盐酸)和苦(尿素)以及两种嗅觉刺激物(吡啶和硝基苯)的检测和识别阈值。治疗前,14例患者(83%)观察到至少一种刺激物的味觉敏锐度下降(味觉减退);最常见的异常是对苦味刺激物的检测和识别。治疗前两种嗅觉刺激物的检测阈值也明显升高(嗅觉减退)。甲状腺激素治疗在很大程度上逆转了味觉和嗅觉缺陷。在一名患者中,用甲状腺素治疗16天后,味觉和嗅觉异常完全得到纠正。这项研究表明,味觉和嗅觉缺陷是原发性甲状腺功能减退症常见的临床异常,并表明这些缺陷可能导致经常观察到的厌食和食欲不振。